30 articles for CJ Swain
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
36
Novel 5-HT3 antagonists: indol-3-ylspiro(azabicycloalkane-3,5'(4'H)-oxazoles).
Merck Sharp and Dohme Research Laboratories
49
Novel 5-HT3 antagonists. Indole oxadiazoles.
Merck Sharp and Dohme Research Laboratories
7
An orally active, water-soluble neurokinin-1 receptor antagonist suitable for both intravenous and oral clinical administration.
Merck
13
High affinity, selective neurokinin 2 and neurokinin 3 receptor antagonists from a common structural template.
Merck Sharp Laboratory
14
3-Benzyloxy-2-phenylpiperidine NK1 antagonists: the influence of alpha methyl substitution
TBA
5
Piperidine-ether based hNK1 antagonists 1: Determination of the relative and absolute stereochemical requirements
TBA
4
Quinuclidine based NK-1 antagonists 2: determination of the absolute stereochemical requirements
TBA
28
Identification and optimisation of 5-amino-7-aryldihydro-1,4-diazepines as 5-HT2A ligands.
Merck Sharp and Dohme Research Laboratories
12
Novel lactam NK1 antagonists with anti-emetic activity.
Merck Sharp & Dohme Research Laboratories
13
Synthesis and structure-activity relationships of 8-azabicyclo[3.2.1]octane benzylamine NK1 antagonists.
Merck Sharp & Dohme Research Laboratories
10
Spirocyclic NK(1) antagonists II: [4.5]-spiroethers.
Merck Sharp & Dohme Research Laboratories
19
Spirocyclic NK(1) antagonists I: [4.5] and [5.5]-spiroketals.
Merck Sharp and Dohme Research Laboratories
16
4,4-Disubstituted cyclohexylamine NK(1) receptor antagonists II.
Merck Sharp & Dohme Research Laboratories
19
4,4-Disubstituted cyclohexylamine NK(1) receptor antagonists I.
Merck Sharp & Dohme Research Laboratories
19
2-Aryl indole NK(1) antagonists: optimisation of the amide substituent.
Merck Sharp & Dohme Research Laboratories
27
2-Aryl indole NK1 receptor antagonists: optimisation of the 2-aryl ring and the indole nitrogen substituent.
Merck Sharp and Dohme Research Laboratories
27
2-Aryl indole NK1 receptor antagonists: optimisation of indole substitution.
The Neuroscience Research Centre
18
High affinity phenylglycinol-based NK1 receptor antagonists.
Merck Sharp and Dohme Research Laboratories
37
4,4-Disubstituted piperidine high-affinity NK1 antagonists: structure-activity relationships and in vivo activity.
Merck Sharp and Dohme Research Laboratories
11
N-heteroaryl-2-phenyl-3-(benzyloxy)piperidines: a novel class of potent orally active human NK1 antagonists.
Merck Sharp and Dohme Research Laboratories
11
N-acyl-L-tryptophan benzyl esters: potent substance P receptor antagonists.
Merck Sharp and Dohme Research Laboratories
31
Identification of L-tryptophan derivatives with potent and selective antagonist activity at the NK1 receptor.
Merck Sharp and Dohme Research Laboratories